ZYUS — Zyus Life Sciences Share News
0.000.00%
Last trade - 00:00- CA$25.77m
- CA$49.40m
- CA$0.41m
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan
Brief: ZYUS Life Sciences Announces Closing Of Unit Offering
Brief: Zyus Life Sciences Finalizing Site Initiation For Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
Brief: Zyus Life Sciences Corporation Announces Close Of Unsecured Loan And Amendment To Prior Unsecured Loans
Brief: Zyus Life Sciences Corporation Announces Unsecured Loan
Brief: ZYUS Life Sciences Receives No Objection Letter from Health Canada for Proof-of-Concept Trial
Brief: ZYUS Life Sciences Receives Cannabis Drug License From Health Canada
Brief: Zyus Announces Anticipated Delay In Its Annual Filings
Brief: ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
Brief: Calian Wins Contract To Support Clinical Trial For Zyus Life Sciences’ Lead Drug Product Candidate
Brief: Zyus Strengthens Leadership Team With Appointment Of Vice President Of Clinical Research
Brief: Zyus Life Sciences Corp Announces Issuance Of Shares For Debt Settlement
Brief: ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules For Advanced Cancer Pain Management
Brief: Zyus Life Sciences Corporation Obtains Health Canada Security Clearance For New Board Member Wayne Brownlee
Brief: Phoenix Canada Oil Company Limited Receives Conditional Approval For Reverse Takeover Transaction With Zyus Life Sciences Inc.
Brief: Phoenix Canada Oil Company Limited Signs Letter Of Intent For Reverse Takeover Transaction With Zyus Life Sciences Inc